Literature DB >> 17597816

Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression.

William K Kaufmann1, Kathleen R Nevis, Pingping Qu, Joseph G Ibrahim, Tong Zhou, Yingchun Zhou, Dennis A Simpson, Jennifer Helms-Deaton, Marila Cordeiro-Stone, Dominic T Moore, Nancy E Thomas, Honglin Hao, Zhi Liu, Janiel M Shields, Glynis A Scott, Norman E Sharpless.   

Abstract

Defects in DNA damage responses may underlie genetic instability and malignant progression in melanoma. Cultures of normal human melanocytes (NHMs) and melanoma lines were analyzed to determine whether global patterns of gene expression could predict the efficacy of DNA damage cell cycle checkpoints that arrest growth and suppress genetic instability. NHMs displayed effective G1 and G2 checkpoint responses to ionizing radiation-induced DNA damage. A majority of melanoma cell lines (11/16) displayed significant quantitative defects in one or both checkpoints. Melanomas with B-RAF mutations as a class displayed a significant defect in DNA damage G2 checkpoint function. In contrast the epithelial-like subtype of melanomas with wild-type N-RAS and B-RAF alleles displayed an effective G2 checkpoint but a significant defect in G1 checkpoint function. RNA expression profiling revealed that melanoma lines with defects in the DNA damage G1 checkpoint displayed reduced expression of p53 transcriptional targets, such as CDKN1A and DDB2, and enhanced expression of proliferation-associated genes, such as CDC7 and GEMININ. A Bayesian analysis tool was more accurate than significance analysis of microarrays for predicting checkpoint function using a leave-one-out method. The results suggest that defects in DNA damage checkpoints may be recognized in melanomas through analysis of gene expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597816      PMCID: PMC2753794          DOI: 10.1038/sj.jid.5700935

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  65 in total

1.  Oncogenic H-ras induces cyclin B1 expression in a p53-independent manner.

Authors:  Carla Santana; Enrique Ortega; Alejandro García-Carrancá
Journal:  Mutat Res       Date:  2002-10-31       Impact factor: 2.433

2.  Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.

Authors:  C Y Peng; P R Graves; R S Thoma; Z Wu; A S Shaw; H Piwnica-Worms
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

Review 3.  Cell-cycle checkpoints and cancer.

Authors:  Michael B Kastan; Jiri Bartek
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

4.  Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival.

Authors:  Eva Grafström; Suzanne Egyházi; Ulrik Ringborg; Johan Hansson; Anton Platz
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

5.  Oncogenic RAS induces accelerated transition through G2/M and promotes defects in the G2 DNA damage and mitotic spindle checkpoints.

Authors:  Jeffrey A Knauf; Bin Ouyang; Erik S Knudsen; Kenji Fukasawa; George Babcock; James A Fagin
Journal:  J Biol Chem       Date:  2005-11-29       Impact factor: 5.157

6.  Frequency of UV-inducible NRAS mutations in melanomas of patients with germline CDKN2A mutations.

Authors:  Malihe Eskandarpour; Jamileh Hashemi; Lena Kanter; Ulrik Ringborg; Anton Platz; Johan Hansson
Journal:  J Natl Cancer Inst       Date:  2003-06-04       Impact factor: 13.506

7.  Lifetime risks of common cancers among retinoblastoma survivors.

Authors:  Olivia Fletcher; Douglas Easton; Kristin Anderson; Clare Gilham; Marcelle Jay; Julian Peto
Journal:  J Natl Cancer Inst       Date:  2004-03-03       Impact factor: 13.506

8.  Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

Authors:  Soledad R Alonso; Pablo Ortiz; Marina Pollán; Beatriz Pérez-Gómez; Lydia Sánchez; Ma Jesús Acuña; Raquel Pajares; Francisco J Martínez-Tello; Carlos M Hortelano; Miguel A Piris; José L Rodríguez-Peralto
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

9.  Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma.

Authors:  Nancy E Thomas; Sharon N Edmiston; Audrey Alexander; Robert C Millikan; Pamela A Groben; Honglin Hao; Dawn Tolbert; Marianne Berwick; Klaus Busam; Colin B Begg; Dianne Mattingly; David W Ollila; Chiu Kit Tse; Amanda Hummer; Julia Lee-Taylor; Kathleen Conway
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-05       Impact factor: 4.254

10.  Gene expression patterns associated with p53 status in breast cancer.

Authors:  Melissa A Troester; Jason I Herschkowitz; Daniel S Oh; Xiaping He; Katherine A Hoadley; Claire S Barbier; Charles M Perou
Journal:  BMC Cancer       Date:  2006-12-06       Impact factor: 4.430

View more
  32 in total

1.  Similar nucleotide excision repair capacity in melanocytes and melanoma cells.

Authors:  Shobhan Gaddameedhi; Michael G Kemp; Joyce T Reardon; Janiel M Shields; Stephanie L Smith-Roe; William K Kaufmann; Aziz Sancar
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

2.  Is activation of the intra-S checkpoint in human fibroblasts an important factor in protection against UV-induced mutagenesis?

Authors:  Christopher D Sproul; Shangbang Rao; Joseph G Ibrahim; William K Kaufmann; Marila Cordeiro-Stone
Journal:  Cell Cycle       Date:  2013-09-25       Impact factor: 4.534

Review 3.  Zebrafish models of p53 functions.

Authors:  Narie Y Storer; Leonard I Zon
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05-05       Impact factor: 10.005

4.  Effective intra-S checkpoint responses to UVC in primary human melanocytes and melanoma cell lines.

Authors:  Marila Cordeiro-Stone; John J McNulty; Christopher D Sproul; Paul D Chastain; Eugene Gibbs-Flournoy; Yingchun Zhou; Craig Carson; Shangbang Rao; David L Mitchell; Dennis A Simpson; Nancy E Thomas; Joseph G Ibrahim; William K Kaufmann
Journal:  Pigment Cell Melanoma Res       Date:  2015-11-03       Impact factor: 4.693

5.  Mechanisms of chromosomal instability in melanoma.

Authors:  William K Kaufmann; Craig C Carson; Bernard Omolo; Adam J Filgo; Maria J Sambade; Dennis A Simpson; Janiel M Shields; Joseph G Ibrahim; Nancy E Thomas
Journal:  Environ Mol Mutagen       Date:  2014-02-24       Impact factor: 3.216

Review 6.  Roles of UVA radiation and DNA damage responses in melanoma pathogenesis.

Authors:  Aiman Q Khan; Jeffrey B Travers; Michael G Kemp
Journal:  Environ Mol Mutagen       Date:  2018-02-21       Impact factor: 3.216

7.  Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approach.

Authors:  Milcah C Scott; Aaron L Sarver; Katherine J Gavin; Venugopal Thayanithy; David M Getzy; Robert A Newman; Gary R Cutter; Kerstin Lindblad-Toh; William C Kisseberth; Lawrence E Hunter; Subbaya Subramanian; Matthew Breen; Jaime F Modiano
Journal:  Bone       Date:  2011-05-15       Impact factor: 4.398

8.  Revised genetic requirements for the decatenation G2 checkpoint: the role of ATM.

Authors:  Jacquelyn J Bower; Yingchun Zhou; Tong Zhou; Dennis A Simpson; Sonnet J Arlander; Richard S Paules; Marila Cordeiro-Stone; William K Kaufmann
Journal:  Cell Cycle       Date:  2010-04-15       Impact factor: 4.534

9.  Targeted deactivation of cancer-associated fibroblasts by β-catenin ablation suppresses melanoma growth.

Authors:  Linli Zhou; Kun Yang; R Randall Wickett; Ana Luisa Kadekaro; Yuhang Zhang
Journal:  Tumour Biol       Date:  2016-08-29

10.  A prognostic signature of G(2) checkpoint function in melanoma cell lines.

Authors:  Bernard Omolo; Craig Carson; Haitao Chu; Yingchun Zhou; Dennis A Simpson; Jill E Hesse; Richard S Paules; Kristine C Nyhan; Joseph G Ibrahim; William K Kaufmann
Journal:  Cell Cycle       Date:  2013-03-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.